PiclamilastAlternative Names: Piclamast; RP 73401; RPR 73401
Latest Information Update: 17 Dec 2003
At a glance
- Originator Aventis
- Class Benzamides; Pyridines; Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Dermatitis; Rheumatoid arthritis
- Discontinued Asthma